Michael Pacini

Statistics

Publications

Citations

839

H-Index

Active since

1998

Affiliations

University of Illinois Hospital & Health Sciences System(Current)

University of Illinois Chicago

Michael Pacini is an author at University of Illinois Hospital & Health Sciences System specializing in medicine, oncology, and gemcitabine-based therapy.

Publications per year

1998–2017

Publications

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum

Vito Lorusso, C. F. Pollera, Mauro Antimi et al. · European Journal of Cancer · 1998 · 289 citations

Medicine, Oncology, Urology +11

Gemcitabine in the Treatment of Refractory Hodgkin’s Disease: Results of a Multicenter Phase II Study

Armando Santoro, Henning Bredenfeld, Liliana Devizzi et al. · Journal of Clinical Oncology · 2000 · 228 citations

Medicine, Oncology, Pharmacotherapy +17

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study

Robert E. Molokie, Donald Lavelle, Michel Gowhari et al. · PLoS Medicine · 2017 · 146 citations · Full text

Medicine, Hematology, Pharmacology +12

Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study

Rishi Lulla, Stewart Goldman, Tohru Yamada et al. · Neuro-Oncology · 2016 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Mutations of the APC Gene in Human Sporadic Colorectal Cancers

Carlotta De Filippo, Cristina Luceri, Giovanna Caderni et al. · Scandinavian Journal of Gastroenterology · 2002 · 36 citations · Full text

Medicine, Oncology, Pathology +11

1–5 of 5